World Alzheimer’s Month 2026: Why an Early Diagnosis Matters for Orange County Families

The short version: World Alzheimer’s Month runs throughout September, with World Alzheimer’s Day on September 21. The 2026 global theme from Alzheimer’s Disease International is built entirely around timely diagnosis: what it can mean medically, and what it unlocks for a family in terms of real, structured support. For Orange County families, that support includes Medicare’s GUIDE Model respite benefit (up to $2,625 a year for PY2026), CalAIM community supports, and clearer IHSS planning, all of which generally require a documented dementia diagnosis to access.

A Different September Than June, On Purpose

If the timing feels familiar, it’s worth being precise about why. Earlier this year, we covered Alzheimer’s & Brain Awareness Month, which runs every June and is led by the Alzheimer’s Association here in the United States. World Alzheimer’s Month is a separate, September-long observance led globally by Alzheimer’s Disease International (ADI), a UK-based federation of Alzheimer’s and dementia associations around the world, with World Alzheimer’s Day falling on September 21 each year. The two observances are not competing with each other, and they don’t cover the same ground. June’s focus tends to be broad brain health and general awareness. September’s 2026 campaign is narrower and more actionable: it’s specifically about the diagnosis itself, why families delay getting one, and why that delay has real consequences. If you read our June piece already, this article isn’t a repeat of it. Think of September as the “now do something about it” follow-up to June’s “here’s what to watch for.”

Why a Timely Diagnosis Matters Medically

The medical case for an earlier diagnosis has gotten measurably stronger in the past few years. Two disease-modifying treatments, lecanemab (marketed as Leqembi) and donanemab (marketed as Kisunla), have received full FDA approval specifically for people in the early stages of Alzheimer’s disease, meaning mild cognitive impairment or mild dementia with confirmed amyloid buildup in the brain. Both work by clearing amyloid plaques, and in clinical trials both showed a statistically meaningful slowing of cognitive decline compared to a placebo, though neither is a cure and neither works once the disease has progressed into moderate or advanced stages. That “only works early” detail is the whole point of this year’s ADI theme: these treatments simply are not an option for a family that waits two or three years past the first noticeable changes to get an evaluation. A timely diagnosis isn’t just about naming what’s happening. For patients who qualify, it can be the difference between having a disease-modifying treatment on the table at all and being told, sympathetically, that the window has closed. Because eligibility, dosing, and monitoring protocols for these treatments are still evolving and vary by patient, this is a conversation to have directly with a neurologist or memory specialist, not something to self-diagnose from a headline.

Noticing a change and actually saying it out loud to a doctor is usually the hardest part of the whole process.

What a Documented Diagnosis Unlocks for Orange County Families

Beyond the medical door it opens, a documented dementia diagnosis is also the administrative key to nearly every structured caregiving support available to Orange County families today. We’ve written before about Medicare’s GUIDE Model, the federal dementia care coordination program that pairs a family with a care navigator and includes a respite care benefit, and about how that respite benefit resets each July. What’s worth restating clearly here: the correct GUIDE Model respite cap for program year 2026 is $2,625 per year, per CMS’s own MLN7172818 guidance, not an older figure you may have seen cited elsewhere. GUIDE enrollment requires a documented dementia diagnosis from a qualified clinician before a family can access any of it, which means the diagnosis has to come first. The same is true, in different ways, for CalAIM’s Community Supports program, which can help pay for services like personal care and respite for Medi-Cal members with qualifying conditions, and for a clear-eyed IHSS eligibility conversation, where a documented cognitive diagnosis often changes the assessed level of need. None of these programs can help a family that hasn’t taken the first step of getting an actual diagnosis on record.

Program	What It Offers	Diagnosis Required?
GUIDE Model (Medicare)	Care navigator, caregiver training, up to $2,625/year respite (PY2026)	Yes, documented dementia diagnosis
CalAIM Community Supports	Personal care, respite, and related services for qualifying Medi-Cal members	Generally yes, a qualifying documented condition
IHSS	In-home supportive services hours based on assessed need	Not strictly required, but a diagnosis often supports a stronger assessment

The New, Easier Path to Getting Diagnosed

The good news is that the path to a diagnosis has gotten shorter and less invasive in just the past few weeks. As we covered in detail in our recent piece on the new FDA-cleared Alzheimer’s blood tests, the FDA cleared two new blood-based biomarker tests in August 2026 alone, C2N Diagnostics’ PrecivityAD2 and Roche’s Elecsys pTau217, bringing the total to four cleared blood tests in a field that had none before May 2025. That matters directly for this September’s theme, because the biggest historical barrier to a timely diagnosis wasn’t willpower. It was the process itself: a PET scan that isn’t always covered or available nearby, or a spinal tap that understandably scares people off. A blood draw, ordered by a primary care doctor as part of an evaluation for someone already showing symptoms, is a dramatically lower barrier than either of those. It doesn’t replace a doctor’s clinical judgment, and it isn’t a stand-alone diagnosis or a general screening test for someone with no symptoms. But for a family that has been putting off “the appointment” because the testing process itself sounded intimidating, that excuse has gotten a lot weaker this year.

A documented diagnosis is what opens the door to structured support, from GUIDE Model respite to CalAIM community services.

How to Start the Conversation This September

The most useful thing most families can do during World Alzheimer’s Month isn’t reading another article. It’s making one phone call. Start with the primary care doctor, and come prepared with specific, dated examples of what’s changed, missed bill payments, repeating the same question within an hour, getting turned around on a familiar drive, rather than a general sense that “mom seems a little off lately.” A doctor who hears concrete examples can act on them; a doctor who hears a vague impression often reasonably suggests waiting and watching. If the primary care doctor isn’t the right fit for a full cognitive workup, ask directly for a referral to a neurologist, geriatrician, or memory specialist. Orange County families also have a dedicated local resource in Alzheimer’s Orange County (AlzOC), a nonprofit that has served the county since 1982 and offers care consultations, education programs, and connections to memory screening opportunities; their helpline can be reached at 844-373-4400. Community memory screening events, often held through local hospitals, senior centers, or organizations like AlzOC around September and World Alzheimer’s Day specifically, are also a low-pressure way to get an initial read before committing to a full medical workup. None of these steps require having all the answers first. They just require making the first call.

Before You Make the Call: Checklist

Click each item as you work through it.

• Write down specific, dated examples of memory or thinking changes you’ve noticed
• Schedule an appointment with the primary care doctor and describe the changes directly
• Ask whether a referral to a neurologist, geriatrician, or memory specialist makes sense
• Ask the doctor whether a blood-based biomarker test like PrecivityAD2 or Elecsys pTau217 is available
• Call Alzheimer’s Orange County (844-373-4400) or a local hospital for memory screening options
• Ask what a diagnostic workup will cost and whether Medicare or insurance covers it
• If a diagnosis is confirmed, ask about eligibility for Medicare’s GUIDE Model care coordination
• Look into CalAIM Community Supports if the family is enrolled in Medi-Cal
• Revisit the IHSS conversation with the diagnosis documented, if not already enrolled
• Start a family conversation about care planning, regardless of the result

Test What You Know

Frequently Asked Questions

The One Thing to Take From This

World Alzheimer’s Month isn’t asking families to do something complicated. It’s asking them to stop waiting on something they’ve probably already noticed. The 2026 theme, “the earlier you know, the more you can do,” is true in two very different ways: medically, because today’s disease-modifying treatments only help in the early stages, and administratively, because nearly every program built to support an Orange County family through a dementia diagnosis, from the GUIDE Model’s respite benefit to CalAIM to a stronger IHSS case, starts with a diagnosis on paper. The tools to get there are better and less invasive than they’ve ever been. The only step left is making the appointment.

This article is provided for general informational purposes and reflects publicly available information from Alzheimer’s Disease International (alzint.org), the FDA, CMS guidance (MLN7172818), and Alzheimer’s Orange County (alzoc.org), current as of August 30, 2026. It is not medical, diagnostic, legal, or insurance advice. Program eligibility, treatment guidance, and coverage policies can change; confirm current details with a physician, CMS, or the relevant program administrator before making care or benefits decisions. At Home VA Staffing is a home care staffing agency, not a medical or diagnostic provider.

← Back to All Articles